CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Yaletown Capital Corp. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Yaletown Capital Corp.
21320 Gordon Way
Unit 120
Phone: (604) 270-0800p:604 270-0800 Richmond, BC  V6W 1J8  Canada
This company is no longer actively traded on any major stock exchange.
Business Summary
Yaletown Capital Corp is a Canada-based company. On July 28, 2010, the Company completed its qualifying transaction. The Company acquired all of the issued and outstanding common shares of 0695955 B.C. Ltd., doing business as Freedom Bionics (Freedom). Freedom became a wholly owned subsidiary of the Company after the completion of qualifying transaction. Freedom is a technology based company engaged in providing specialized engineering services, and in undertaking its own research and development related to certain health care products and services. Freedom’s principal research and development focus is on helping patients suffering from the effects of cognitive impairment (especially memory loss) that typically results from the aging process. Freedom also generates revenue related to fee-for-service consulting in its areas of expertise.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20136/30/2012Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Douglas A.Kind 2/20/2012 7/28/2010
Secretary, Director Neil S.Allen 3/7/2012 3/7/2012
Independent Director MarkWeisbrod 7/30/2010 4/4/2007

General Information
Outstanding Shares: 17,005,855 (As of 12/31/2014)
Stock Exchange: NEX


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023